Tirzepatide for PCOS: Tirzepatide Shows Promise for Treatment of Polycystic Ovary Syndrome (PCOS)
What is PCOS? Polycystic ovarian syndrome (PCOS) is a common hormonal disorder that affects around 10–15% of women of reproductive age worldwide. Irregular menstrual cycles, signs of excess androgen hormones, including acne and hirsutism, insulin resistance, obesity, and infertility, frequently occur as a result of this condition. It has become
Sermorelin Peptide: Another Option for Weight Loss
Introduction Compounded sermorelin peptide therapy is an innovative, off-label approach for adults seeking weight loss, especially those who cannot tolerate GLP-1 agonists such as semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro), or similar medications, or those of you who are not candidates for GLP-1 agonist therapy in the first place. Sermorelin is
Compounded Tirzepatide: A Dual-Action Peptide
Tirzepatide is the first medication in a new drug class sometimes known as a twincretin, because it targets two hormone receptors that regulate insulin and metabolism. Although tirzepatide was initially developed to treat type 2 diabetes, it has demonstrated significant effects on weight loss and has been rapidly adopted under
Sermorelin Therapy: Benefits, Side Effects, and Clinical Evidence
Sermorelin Sermorelin is a synthetic peptide (group of amino acids) that mimics the action of growth hormone-releasing hormone (GHRH), a natural substance produced in thebrain. By stimulating the front of the pituitary gland, sermorelin increases the body’s own production of growth hormone (GH), which in turn raises levels of insulin-likegrowth